Company Filing History:
Years Active: 2025
Title: Christoph Hohn: Innovator in Pharmaceutical Chemistry
Introduction
Christoph Hohn is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that target specific receptors in the brain.
Latest Patents
Hohn holds a patent for "Substituted pyrazine-carboxamide derivatives." This invention relates to compounds of formula I, a process for their manufacture, pharmaceutical compositions containing them, and their use in therapy. The focus of this patent is particularly on the treatment and/or prevention of conditions associated with the function of metabotropic glutamate receptor subtype 4 (mGluR4). His work in this area highlights the potential for new therapeutic approaches in medicine.
Career Highlights
Christoph Hohn is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development, where he applies his expertise in chemistry to create innovative solutions for health-related challenges.
Collaborations
Hohn has collaborated with esteemed colleagues such as Roland Pfau and Georg Dahmann. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Christoph Hohn's contributions to pharmaceutical chemistry, particularly through his patent on substituted pyrazine-carboxamide derivatives, demonstrate his commitment to advancing medical science. His work continues to pave the way for innovative therapies that can improve patient outcomes.